These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4269210)

  • 1. Pharmacology of fusaric acid in man.
    Matta RJ; Wooten GF
    Clin Pharmacol Ther; 1973; 14(4):541-6. PubMed ID: 4269210
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of fusaric acid (a dopamine beta-hydroxylase inhibitor) on phaeochromocytoma.
    Nagasaka A; Hara I; Imai Y; Uchikawa T; Yamauchi K; Suzuki S; Takatsuki K; Tomita A; Niinomi M; Nakagawa H
    Clin Endocrinol (Oxf); 1985 Apr; 22(4):437-44. PubMed ID: 3987067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of fusaric acid, inhibitor of dopamine -hydroxylase, on reaction to alcohol in chronic alcoholics: clinical findings.
    Ogata M; Sanada H; Teraoka M
    Folia Psychiatr Neurol Jpn; 1972 Jan; 26(1):1-5. PubMed ID: 5068469
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of fusaric acid on urinary excretion of catecholamines: a clinical study with particular emphasis on the characteristics of its time-course change.
    Ozawa N
    Jpn Circ J; 1972 Nov; 36(11):1205-21. PubMed ID: 4678992
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of human serum dopamine -hydroxylase after the oral administration of fusaric acid.
    Nagatsu T; Kato T; Kuzuya H; Okada T; Umezawa H; Takeuchi T
    Experientia; 1972 Jul; 28(7):779-80. PubMed ID: 4658852
    [No Abstract]   [Full Text] [Related]  

  • 6. Blood pressure decreased by halobutylpicolinic acid, an inhibitor of dopamine beta-hydroxylase.
    Hidaka H; Takeya K
    Nature; 1972 Oct; 239(5371):334-5. PubMed ID: 12635227
    [No Abstract]   [Full Text] [Related]  

  • 7. 24-hour rhythm of human plasma noradrenaline and the effect of fusaric acid, a dopamine-beta-hydroxylase inhibitor.
    Kato T; Hashimoto Y; Nagatsu T; Shinoda T; Okada T; Takeuchi T; Umezawa H
    Neuropsychobiology; 1980; 6(2):61-5. PubMed ID: 7354907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral effects of a new dopamine-beta-hydroxylase inhibitor (fusaric acid) in man.
    Goodwin FK; Sack RL
    J Psychiatr Res; 1974; 11():211-7. PubMed ID: 4618285
    [No Abstract]   [Full Text] [Related]  

  • 9. Selective inhibition of dopamine-beta-hydroxylase in the peripheral tissues by 5-dimethyldithiocarbamylpicolinic acid; its effect on stress-induced ulcer, ethanol-induced sleep and blood pressure.
    Hidaka H; Hara F; Harada N; Hashizume Y; Yano M
    J Pharmacol Exp Ther; 1974 Dec; 191(3):384-92. PubMed ID: 4473535
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of dopamine-beta-hydroxylase inhibitors on blood pressure and cardiac norepinephrine levels in rats subjected to immobilization stress.
    Ishii Y; Mimura C; Homma M
    J Pharmacol Exp Ther; 1976 Sep; 198(3):589-95. PubMed ID: 988175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of dopamine beta-hydroxylase in blood vessels by picolinic acid derivatives in vivo and their anthypertensive effects.
    Hidaka H; Shoka F; Hashizume Y; Takemoto N; Yamamoto M
    Jpn J Pharmacol; 1975 Oct; 25(5):515-24. PubMed ID: 1221134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Proceedings: Effect of a dopamine-beta-hydroxylase inhibitor (fusaric acid) on thyroid hormones and TSH].
    Yoshimura M; Yatani T; Ochi Y; Nagasaka A; Takeda A
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):88. PubMed ID: 4476662
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter: Fusaric acid derivatives: the effect on dopamine beta-hydroxylase.
    Umezawa H; Takeuchi T; Miyano K; Koshigoe K; Hamano H
    J Antibiot (Tokyo); 1973 Mar; 26(3):189. PubMed ID: 4205877
    [No Abstract]   [Full Text] [Related]  

  • 14. Selective suppression of rapid eye movement sleep (REM) by fusaric acid, an inhibitor of dopamine- -oxidase.
    Sato T; Tanaka R
    Experientia; 1973 Feb; 29(2):177-8. PubMed ID: 4348192
    [No Abstract]   [Full Text] [Related]  

  • 15. Proceedings: In vivo inhibition of dopamine beta-hydroxylase and blood pressure.
    Hidaka H; Hara F; Harada N; Asano M
    Jpn J Pharmacol; 1974; 24(0):s:25. PubMed ID: 4545737
    [No Abstract]   [Full Text] [Related]  

  • 16. SCH 10595, an effective dopamine- -hydroxylase inhibitor and a hypotensive agent.
    Korduba CA; Veals J; Wohl A; Symchowicz S; Tabachnick II
    J Pharmacol Exp Ther; 1973 Mar; 184(3):671-7. PubMed ID: 4687230
    [No Abstract]   [Full Text] [Related]  

  • 17. Analogues of fusaric (5-butylpicolinic) acid as potent inhibitors of dopamine -hydroxylase.
    Hidaka H; Asano T; Takemoto N
    Mol Pharmacol; 1973 Mar; 9(2):172-7. PubMed ID: 4197141
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experimental and clinical studies on the activity of human serum dopamine-beta-hydroxylase].
    Yashima O
    Nihon Naibunpi Gakkai Zasshi; 1973 Jan; 49(1):48-59. PubMed ID: 4734771
    [No Abstract]   [Full Text] [Related]  

  • 19. [Substituted picolinic acids as DBH inhibitors. Inhibition of dopamine beta-hydroxylase and antihypertensive action].
    Piesche L; Hilse H; Oehlke J; Schrötter E; Oehme P
    Pharmazie; 1983 May; 38(5):335-8. PubMed ID: 6611632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of fusaric acid calcium on catecholamine metabolism and its clinical effects on essential hypertension].
    Ozawa M; Nakajima Y; Suzuki K; Sato T; Takahashi E
    Horumon To Rinsho; 1976 Jan; 24(1):79-86. PubMed ID: 942902
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.